Steigerung der Therapiequalität beim frühen Ovarialkarzinom: Ergebnisse der QS-Ovar

Autor: P Wimberger, J Pfisterer, A du Bois, F Hilpert, M Kerkmann, J Sehouli, S Mahner, N de Gregorio, L Hanker, F Heitz, F Marmé, L Wölber, L Holtmann, G Elser, P Harter

Publikováno v: 64. Kongress der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe e. V..

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::45255d6bda42c0cfae4812fcbbfe5f4a
https://doi.org/10.1055/s-0042-1757107

Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer

Autor: Harter, Philipp, Sehouli, Jalid, Vergote, Ignace, Ferron, Gwenael, Reuss, Alexander, Meier, Werner, Greggi, Stefano, Mosgard, Berit J, Selle, Frederic, Guyon, Frédéric, Pomel, Christophe, Lécuru, Fabrice, Zang, Rongyu, Avall-Lundqvist, Elisabeth, Kim, Jae-Weon, Ponce, Jordi, Raspagliesi, Francesco, Kristensen, Gunnar, Classe, Jean-Marc, Hillemanns, Peter, Jensen, Pernille, Hasenburg, Annette, Ghaem-Maghami, Sadaf, Mirza, Mansoor R, Lund, Bente, Reinthaller, Alexander, Santaballa, Ana, Olaitan, Adeola, Hilpert, Felix, du Bois, Andreas, S Buchholz, A Burges, U Canzler, D Denschlag, A El-Balat, G Emons, R Felberbaum, N de Gregorio, M Gropp-Meier, V Hanf, L Hanker, R Hils, C Kurzeder, B Lampe, A Mustea, M Schmidt, R Schutz, M Weigel, S Weiser, A Zorr, C Marth, E Petru, T Scholl, M Beltran, I Bover, A Gomez di Laino, N Lainez, S Martinez, A Poveda Velasco, M Romeo, H Crouet, E de Gournay, G Deplanque, P Follana, A Floquet, D Lanvin, J Leveque, E Pujade-Lauraine, N Raban, B Resch, A M Savoye, G Aletti, G Giorda, F Landoni, C Scaffa, J Abu, F Alexander-Sefre, D Barton, S Butler-Manuel, R Clayton, R Crawford, T Duncan, A El-Ghobashy, C Fotopoulou, M Hall, C Intrivici, A Lawrence, D Luesley, R Naik, A Nordin, J Tidy, L Fokdahl, A Hofsjö, P Kjolhede, B Eyjolfsdottir, Z Y Dai, P Zhang, B Aminossadati, M Hahmann, C Nasemann, S Yahiaoui, M Wittenberg, C Schade-Brittinger, G Elser, D Reddig, M Kuncke, S Polleis, Y Mattukat, A Riha, R Berger, J de Roover, B Kaur, J Crook, F Nepote, B Votan, M Andriamamonjy, J Bryce, S Ristinge

Publikováno v: Harter, P, Sehouli, J, Vergote, I, Ferron, G, Reuss, A, Meier, W, Greggi, S, Mosgard, B J, Selle, F, Guyon, F, Pomel, C, Lécuru, F, Zang, R, Avall-Lundqvist, E, Kim, J-W, Ponce, J, Raspagliesi, F, Kristensen, G, Classe, J-M, Hillemanns, P, Jensen, P, Hasenburg, A, Ghaem-Maghami, S, Mirza, M R, Lund, B, Reinthaller, A, Santaballa, A, Olaitan, A, Hilpert, F, du Bois, A & DESKTOP III Investigators 2021, ' Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer ', The New England Journal of Medicine, vol. 385, no. 23, pp. 2123-2131 . https://doi.org/10.1056/NEJMoa2103294
NEW ENGLAND JOURNAL OF MEDICINE
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Harter, P, Sehouli, J, Vergote, I, Ferron, G, Reuss, A, Meier, W, Greggi, S, Mosgard, B J, Selle, F, Guyon, F, Pomel, C, Lécuru, F, Zang, R, Avall-Lundqvist, E, Kim, J W, Ponce, J, Raspagliesi, F, Kristensen, G, Classe, J M, Hillemanns, P, Jensen, P, Hasenburg, A, Ghaem-Maghami, S, Mirza, M R, Lund, B, Reinthaller, A, Santaballa, A, Olaitan, A, Hilpert, F & Du Bois, A 2021, ' Randomized trial of cytoreductive surgery for relapsed ovarian cancer ', New England Journal of Medicine, vol. 385, no. 23, pp. 2123-2131 . https://doi.org/10.1056/NEJMoa2103294

BACKGROUND: Treatment for patients with recurrent ovarian cancer has been mainly based on systemic therapy. The role of secondary cytoreductive surgery is unclear. METHODS: We randomly assigned patients with recurrent ovarian cancer who had a first r

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9f31361614653d123d3ce643aeba6c3
https://vbn.aau.dk/da/publications/7ebaa8eb-4c70-44c3-82d4-fe478c1c7475

449 Harmonization operations for global trials to overcome obstacles from 2004 – 2017: gynecologic cancer intergroup (GCIG)

Autor: Laura Farrelly, Y Kajimoto, B Votan, M Bacon, K Carty, E Aotani, A Negrouk, J Martyn, B Stonebraker, G Elser, Jane Bryce

Publikováno v: E-Poster viewings.

Objectives The Gynecologic Cancer InterGroup (GCIG) is a global consortium consisting of research groups from various countries to facilitate collaboration in clinical trials in gynecologic cancer; founded in 1993 and formalized in 1997. Global clini

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::62013671b920d80b2d8c9b4c3843824e
https://doi.org/10.1136/ijgc-2019-igcs.449

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Addition of vandetanib to pegylated liposomal doxorubicin (PLD) in patients with recurrent ovarian cancer. A randomized phase I/II study of the AGO Study Group (AGO-OVAR 2.13)

Autor: Rainer Kimmig, Christian Kurzeder, Felix Hilpert, Andreas du Bois, Philipp Harter, Jalid Sehouli, Jörn Rau, G. Elser

Publikováno v: Investigational New Drugs. 31:1499-1504

Background PLD is a standard treatment in patients with recurrent platinum-resistant or refractory ovarian cancer. Vandetanib is an oral once daily administered inhibitor of VEGFR-, EGFR- and RET-signaling with activity in combination with chemothera

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32c313da798a1f788dc174c27e364706
https://doi.org/10.1007/s10637-013-0011-3